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ABSTRACT
Thymus-dependent T-cell regeneration is a major pathway for immune reconstitution after stem cell trans-
plantation in children. Therefore, we prospectively assessed T-cell dynamics and thymic function in 164
pediatric patients between 1 and 124 months after transplantation by measuring T-cell receptor recombination
excision circles and spontaneous expression of Ki67 in peripheral T-cell subsets. We analyzed the effect of
recipient age, conditioning regimen, type of donor and graft, stem cell dose, and graft-versus-host disease on
the onset and the plateau of thymic output. A high rate of spontaneous proliferation in early-reconstituting
naive and memory T cells inversely correlated with total T-cell numbers. Accordingly, T-cell receptor
recombination excision circle content was diminished in early-appearing naive T cells. A multivariate analysis
revealed that the onset of thymic recovery was inversely correlated only with recipient age (P< .0002), whereas
the plateau of thymic output was higher in patients receiving increased stem cell numbers (P < .0022). Donor
type, stem cell source, and conditioning regimen influenced none of the analyzed parameters. In conclusion,
lymphopenia-driven proliferation is important for T-cell homeostasis in children early after stem cell trans-
plantation, but it might result in underestimation of thymic function. Onset and plateau of thymic activity are
independently regulated by different transplant-related factors.
© 2005 American Society for Blood and Marrow Transplantation
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NNTRODUCTION
T-cell reconstitution in lymphopenic hosts has
een shown to follow 2 major pathways: peripheral,
ntigen-driven expansion of activated T cells or de
ovo generation of naive T cells from hematopoietic
tem cells in the host thymus [1,2]. Whereas the ﬁrst
athway leads to a restoration of memory-type T cells
n which diversity of the T-cell receptor (TCR) rep-
rtoire is dependent on the number of T-cell precur-
ors in the graft, the latter bears a closer resemblance
o normal T-cell ontogeny and results in reconstitu-
ion of a fully mature T-cell compartment. In humans,
roduction of naive T cells via the second pathway is i
94ependent on a functional thymus, because in congen-
tally athymic patients, such as patients with complete
iGeorge syndrome or patients thymectomized be-
ore an allogeneic transplantation, no naive T cells are
etectable after transplantation [3,4]. However, trans-
lantation of thymic tissue has been able to restore
aive T-cell production in 2 DiGeorge patients [5].
ntil recently, it has been difﬁcult to quantify thymic
unction in humans precisely because of the lack of
peciﬁc markers on recent thymic emigrants (RTEs)
nd the uncertainty of ascribing T cells with a naive
henotype to those recently produced in the thymus.
ovel insights into the mechanisms operational dur-ng TCR rearrangement [6,7] have led to the intro-
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Thymic Function after Pediatric Stem Cell Transplantation
Buction of the TCR excision circle (TREC) assay
4,8], which has been used to quantify thymic function
n a variety of clinical situations [9-17]. However,
nterpretation of TREC data is complex, because the
REC content in the peripheral T-cell compartment
s inﬂuenced not only by thymic output, but also by
ongevity of naive T cells and by dilution of TRECs
hrough ongoing T-cell divisions. It has therefore
een suggested that TREC data can be interpreted
nly together with information about the actual T-cell
urnover state [18,19].
After stem cell transplantation, successful reconsti-
ution of naive T cells has been shown to restore the
iversity of an initially skewed TCR repertoire [11,20],
o increase the secretion of interleukin 2 and expression
f CD69 on peripheral T cells [21], and to result in a
ower risk of disease recurrence after autologous trans-
lantation [16,22]. Because of an increasing awareness of
he importance of naive T-cell regeneration, a number
f studies have recently analyzed TREC values in the
ontext of immune reconstitution after stem cell trans-
lantation [11,13,14,17,23-27]. There is a general con-
ensus that TREC content in peripheral T cells is low
mmediately after transplantation and that the thymus
ontributes substantially to naive T-cell regeneration
ven in adult patients. Most investigators have found a
ositive correlation between TREC content and naive
-cell numbers, as well as TCR repertoire diversity
11,17,23]. Most studies were performed in adult pa-
ients, and in this age group, a negative correlation was
escribed between the patient’s age and TREC values
11,24]. Only 1 study included a small cohort of children,
nd this group exhibited signiﬁcantly higher TRECs
han the larger adult population [27]. Data on other
ransplant-related factors, such as conditioning regimen,
ype of graft, cell dose, and acute or chronic graft-versus-
ost disease (GVHD), are less clear. Although chronic
VHD and a history of resolved GVHD were associ-
ted with low TREC values in 2 studies [17,27], this
ould not be conﬁrmed by Storek et al. [24]. Regarding
he type of graft, higher TRECs were reported for T
ell–replete grafts, but only in the ﬁrst 9 months after
ransplantation or in cases in which children were ex-
luded from the analysis [27]. Douek et al. [11], reported
lightly higher TRECs in recipients of CD34-selected
rafts after 2 years. To date, only 1 study, performed by
azenberg et al. [13], has taken into account the in-
reased T-cell division rates after transplantation, as
easured by the intracellular expression of Ki67. These
uthors found that TREC content after transplantation
as determined by T-cell divisions related to clinical
vents rather than by homeostatic adaptation to lym-
hopenia.
In this prospective study, we investigated a pedi-
tric cohort of 164 children who underwent transplan-
ation at the Children’s Hospital of the University of
übingen between 1991 and 2003. Our cohort could i
B & M Te divided into 4 major categories: recipients of stem
ells from matched sibling, unrelated, or mismatched-
elated donors or of autologous stem cells. A multi-
actorial approach was applied to study the inﬂuence
f several variables—namely, recipient age, condition-
ng regimen, stem cell source and dose, type of donor,
nd acute or chronic GVHD—not only on the plateau
f TREC values, but also on the onset of thymic
ctivity. Furthermore, we determined the T-cell turn-
ver state during different stages of immune reconsti-
ution by measuring the spontaneous expression of
i67 in naive and memory CD4 and CD8, as well
s effector CD8, populations. Our results indicate
hat thymic function may be substantially underesti-
ated when only TREC values or peripheral naive
-cell numbers are used as a surrogate marker for
hymic output. In children, homeostatic proliferation
eems to be an important regulator of T-cell pool size
oon after transplantation and can result in rapid
learance of TREC T cells from the periphery. We
escribe the factors that inﬂuence thymic output and
he onset of thymic activity, namely, recipient age and
ransplanted stem cell dose.
ATIENTS AND METHODS
atients
Between February 2001 and July 2003, a total of
73 samples from 164 children were collected after
yeloablative conditioning and stem cell transplanta-
ion in the outpatient department of our pediatric
tem cell transplant program. Patients had undergone
ransplantation between November 1991 and April
003 at the Children’s Hospital of the University of
übingen. Eighty-three patients underwent trans-
lantation after May 2000 (median age, 7.5 years;
ange, 0.3-22.6 years) and were monitored prospec-
ively to determine the parameters Tmin and PL (pla-
eau level). Tmin describes the earliest time point when
RECs become detectable in a patient after trans-
lantation, and P is a measure of the plateau of thymic
utput, which is generally achieved after 1 to 2 years.
hree samples per patient (median; range, 1-9) were
nalyzed in this cohort, with a median follow-up of
33 days after transplantation (range, 50-1105 days).
ighty-one patients who underwent transplantation
efore May 2000 (median age, 7.3 years; range, 0.5-
9.4 years) could be analyzed only in the plateau phase
PL) of their thymic function. Because in this phase
REC values are considered to be relatively stable
see Statistical Analysis), only 1 sample per patient
median; range, 1-3) was analyzed in this subgroup,
ith a median follow-up duration of 1507 days after
ransplantation (range, 320-3715 days) to estimate PL.
he study was approved by the institutional review
oard, and parental consent was obtained according to
nstitutional guidelines.
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1Patients not surviving beyond day 100 were ex-
luded, whereas patients successfully grafted after a
econd transplantation that was necessary because of
raft rejection or nonengraftment or tandem high-
ose chemotherapy with autologous stem cell rescue
ere included in the study. The cohort could be
rouped into 4 major categories: recipients of autolo-
ous stem cells (n  51) or of cells from an HLA-
atched sibling (n  47), unrelated (n  45), or
arental (haploidentical) donor (n  21). From the
10 patients receiving peripheral blood stem cells
PBSCs), only 6 received unmanipulated PBSCs; all
emaining 104 patients received highly puriﬁed,
D34-selected PBSCs (resulting in a 3-4 log T-cell
epletion) without any posttransplantation immuno-
uppressive therapy. GVHD prophylaxis for recipi-
nts of unmanipulated grafts consisted of cyclosporin
for the ﬁrst 100 to 200 days with subsequent taper-
ng. Conditioning regimens were based either on
usulfan or total body irradiation for allogeneic trans-
lantations or on melphalan/carboplatin for autolo-
ous transplantations. Patient characteristics are listed
n Table 1. The primary indication for transplantation
as a malignant disorder such as leukemia or lym-
homa (n  62) or solid tumor (n  45). Thirty-six
atients underwent transplantation, however, because
f a nonmalignant disease (Table 2).
ell Preparation
Peripheral blood was collected in ethylenediamine-
etraacetic acid–containing tubes, and peripheral mononu-
lear cells (PMNCs) were subsequently isolated by Ficoll-
ypaque density gradient centrifugation. After 2 washes,
ell pellets were frozen immediately at 80°C and stored
ntil analysis of TRECs by quantitative polymerase chain
eaction (PCR). The content of CD3 T cells in the
MNC fraction was determined by ﬂow cytometry on a
ACSCalibur (Becton Dickinson, Heidelberg, Germany)
y using CD3 PerCP-labeled monoclonal antibodies be-
ore freezing. In parallel, the percentages and absolute
umbers of CD3, CD4, and CD8 T cells in each
ample, as well as the naive and memory populations in
ach subset (eg, expression of CD45RA/CD45RO on
D4 and CD45RA/CD27 on CD8 T cells), were de-
ermined in freshly isolated cells by ﬂowcytometry by using
tandard procedures. All monoclonal antibodies were pur-
hased from Becton Dickinson. Starting in March 2002,
he spontaneous intracellular expression of Ki67 was ana-
yzed in parallel in freshly isolated naive and memory
D4 and CD8 populations within 12 hours in all sam-
les (in total, 141 samples from 81 patients). In brief, after
taining of cell-surface markers and ﬁxation with 4% para-
ormaldehyde, cells were permeabilized with 0.3% saponin
Riedel deHaen, Deisenhofen, Germany), stained intracel-
ularly with Ki67 ﬂuorescein isothiocyanate (Coulter-Im-
unotech, Krefeld, Germany), washed twice in 0.1% sa-
96able 1. Patient Characteristics (n  164)
Characteristic n
utologous transplantations (n  51)
Median age, 4.8 y (range, 1-19.4 y)
Transplantation date, November 1991 to
January 2003
Follow-up duration, median, 712 d (range,
50-3715 d)
Solid tumor 42
Leukemia/lymphoma 7
Nonmalignant disease (scleroderma,
Morbus Still)
2
Peripheral blood stem cells (>107/<107
CD34/kg BW)
48 (15/33)
Bone marrow 3
Conditioning (TBI based/busulfan based/
other)
3/5/43
atched sibling donor transplantations (n  47)
Median age, 8.3 y (range, 0.7-19 y)
Transplantation date, June 1992 to October
2002
Follow-up duration, median, 1107 d (range,
99-3703 d)
Leukemia/lymphoma 22
Solid tumor (rhabdomyosarcoma) 2
Myelodysplastic syndrome 8
Nonmalignant disease 15
Peripheral blood stem cells (>107/<107
CD34/kg BW)
11 (3/8)
Bone marrow 36
Conditioning (TBI based/busulfan based/
other)
18/26/3
GVHD (acute/chronic) 27/6
nrelated donor transplantations (n  45)
Median age, 8.9 y (range, 0.3-22.6 y)
Transplantation date, February 1993 to April
2003
Follow-up duration, median, 509 d (range,
76-3065 d)
Leukemia/lymphoma 30
Myelodysplastic syndrome 3
Nonmalignant disease 12
Peripheral blood stem cells (>107/<107
CD34/kg BW)
32 (13/19)
Bone marrow 13
Conditioning (TBI based/busulfan based/
other)
23/20/2
GVHD (acute/chronic) 10/3
arental donor (haploidentical) transplantations
(n  21)
Median age, 7.5 y (range, 0.5-18.3 y)
Transplantation date, March 1995 to March
2003
Follow-up duration, median, 735 d (range,
53-2763 d)
Leukemia/lymphoma 12
Solid tumor 1
Myelodysplastic syndrome 2
Nonmalignant disease 6
Peripheral blood stem cells (>107/<107
CD34/kg BW)
19 (14/5)
Bone marrow 2
Conditioning (TBI based/busulfan based/
other)
13/5/3
GVHD (acute/chronic) 2/3
W indicates body weight; GVHD, graft-versus-host disease; TBI,
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Thymic Function after Pediatric Stem Cell Transplantation
Bonin, and analyzed on a FACSCalibur by usingCellQuest
oftware (Becton Dickinson) [28].
uantitative Real-Time PCR
Quantiﬁcation of TRECs in isolated PMNCs was
erformed by real-time quantitative PCR by means of
he 5= nuclease TaqMan assay with an ABI7700 system
PerkinElmer, Weiterstadt, Germany), as previously de-
cribed [4,11]. Cells were incubated with proteinase K
00 g/mL (Roche, Mannheim, Germany) at a ratio of
0 L per 105 cells for 1 hour at 56°C and then for 15
inutes at 95°C. Real-time quantitative PCR was per-
ormed on 5 L of cell lysate (equivalent to 50 000 cells)
ith the primers 5=-CACATCCCTTTCAACCATGCT
nd 5=-GCCAGCTGCAGGGTTTA-GG and TaqMan
robe FAM-5=-ACACCTCTGGTTTTTGTAAAG-
TGCCCACT-TAMRA (MegaBases, Chicago, IL).
CR reactions contained 0.5 U of Platinum Taq poly-
erase (Invitrogen, Karlsruhe, Germany), 3.5
mol/L MgCl2, deoxynucleoside triphosphate solu-
ion 0.2 mmol/L, 500 nmol/L of each primer, and 200
mol/L probe in a ﬁnal volume of 25 L. Conditions
ere 95°C for 5 minutes, 95°C for 30 seconds, and
0°C for 1 minute for 40 cycles. A standard curve was
lotted, and TREC values for samples were calculated
y the ABI7700 sequence-detector software. Samples
ere analyzed in triplicate.
agnetically Activated Cell Sorting Separation of
aive and Memory T-Cell Subpopulations
Peripheral blood mononuclear cells were collected
rom healthy adult controls (n  5) and patients be-
ore (n  10) and 6 months after transplantation (n 
) by using standard procedures. In the early post-
able 2. Transplantation for Nonmalignant Diseases
Data n
edian age, 4.8 y (range, 0.3-19.4 y)
ransplantation date, December 1992 to
January 2003
ollow-up duration, median, 897 d
(range, 88-3613 d)
Congenital granulocyte disorder 1
Congenital red blood cell defect 2
Hemophagocytic lymphohistiocytosis 1
Metachromatic leukodystrophy 1
X-chromosomal adrenoleukodystrophy 3
Autoimmune diseases 2
Osteopetrosis 5
Polycythemia vera 1
Severe aplastic anemia 11
Severe combined immunodeficiency 1
Shwachman-Diamond syndrome 1
Sickle cell disease 2
Thalassemia 3
Wiskot-Aldrich syndrome 2
Total 36ransplantation phase, when memory T cells domi- a
B & M Tated the peripheral T-cell pool, peripheral blood
ononuclear cells were magnetically activated cell
orted into CD4 and CD8 cells by following the
anufacturer’s protocol, and purity was conﬁrmed by
uorescence-activated cell sorting analysis. When
10% CD4/CD45RA naive-type T cells were de-
ectable in the peripheral blood, peripheral blood
ononuclear cells were sorted into naive (CD45RA)
nd memory (CD45RO) CD4 and CD8 cells by
sing the CD4-Multisort-Kit (Miltenyi, Bergisch-
ladbach, Germany). The median purity of the target
opulations was 87.1% (range, 39.7%-99.8%). Subse-
uently, the TREC content of the respective popula-
ions was measured as described previously.
tatistical Analysis
All patients analyzed in the early posttransplanta-
ion phase had at least 1 TREC-negative sample. On
he basis of this observation and the course of TREC
alues displayed in Figure 1, we developed the follow-
ng model of TREC reconstitution: after an early
hase without detectable TREC T cells in the pe-
ipheral blood, patients start to reconstitute TREC
cells at a time point Tmin during the ﬁrst year after
ransplantation. Approximately 18 to 24 months after
ransplantation, a stable plateau PL of TREC T cells
s achieved in which thymic T-cell neogenesis and
learance of TREC T cells from the peripheral
lood are in balance. The parameter Tmin was as-
umed to have a log-normal distribution whose me-
ian depends linearly on age, because a preliminary
nalysis based on regression of Tmin and age grouped
ccording to quartiles had shown a linear association.
nterval-censoring of the observations because of
issing values was taken into account (81 patients
igure 1. TREC peripheral T cells after stem cell transplantation.
RECs were not detectable in the early phase after transplantation
ut started to increase at time point Tmin. After approximately 1 to
years, TREC T cells reached a stable plateau PL, which re-
ained constant for up to 10 years after transplantation. TREC
alues from all patients were plotted against time after transplanta-
ion. Results are shown as median values; error bars represent 25th
nd 75th percentiles.
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M. Eyrich et al.
1ere studied only in the plateau phase PL). The pa-
ameters were estimated by maximum likelihood. The
ffect of the following variables on Tmin of TREC
 T
ells was analyzed: type of transplantation (autolo-
ous, matched sibling, unrelated, or parental donor),
ype of disease (malignant or nonmalignant), source of
tem cells (PBSCs or bone marrow), transplanted
D34 cell number (107 or 107 CD34 cells per
ilogram body weight), conditioning regimen (total
ody irradiation based, busulfan based, or other), and
resence of GVHD (acute or chronic). Because only
ge and acute GVHD showed a signiﬁcant effect on
min, these 2 factors were entered simultaneously into
multifactorial maximum-likelihood model. The pla-
eau level PL for the 101 patients who achieved
REC-positive values was estimated by their geomet-
ic means and compared for the various subgroups by
-way analysis of variance. To achieve equal variances
mong groups, a logarithmic transformation was ap-
lied. A stepwise multifactorial analysis of variance
as performed that initially entered all the factors
entioned previously for Tmin.. A P value of .05 was
et as the selection criterion.
Assuming a detection limit of Ki67 of 0.1%, we
ompared Ki67 expression before and after day 180 by
sing restricted maximum likelihood by taking the
ensored observations below the detection limit ex-
licitly into account. The logit was deﬁned as the
igure 2. Correlation of TRECs with naive T-cell populations.
fter logarithmic transformation, TREC levels correlated with the
umbers of naive CD4 (A) and naive CD8 (B) cells and with the
otal number of naive CD3 T cells (C). Furthermore, TREC
ontent, given as TRECs per 100 000 T cells, correlated well with
he calculated number of TREC T cells per microliter (D). This
ndicates that both parameters may be used equivalently and that
orrection for peripheral T-cell numbers is usually not necessary; n
ndicates the number of analyzed samples.ogarithm of the odds, ie, the fraction divided by 1 C
98inus the fraction. The different number of samples
mong patients was taken into account by considering
atient number as a random factor. We correlated the
xpression of Ki67 in 5 T-cell subpopulations with
ach other and with the numbers of peripheral CD3
cells. The P values were adjusted according to the
onferroni-Holm method for the number of hypoth-
ses tested in the same data set. The same statistical
ethod was used to compare the TREC content in
agnetically activated cell-sorted T-cell subpopula-
ions. All pairs of T-cell subsets were compared by
sing the Tukey-Kramer honestly signiﬁcant different
est with   .05.
ESULTS
REC Content, Absolute TRECs, and Naive
-Cell Numbers
TREC values were calculated as absolute numbers
f TREC T cells per microliter of peripheral blood
nd as TREC T cells per 100 000 T cells. Values of
REC T cells per microliter showed a strong posi-
ive correlation with the numbers of naive CD4 T
ells (Figure 2A) and naive CD8 T cells (Figure 2B),
s well as with the total number of naive CD3 T cells
Figure 2C). Similar results were obtained for the
orrelation between TREC T cells per 100 000 T
ells and naive T-cell numbers (data not shown).
herefore, under normal circumstances, naive T-cell
umbers in the peripheral blood may be used to esti-
ate TREC values. Furthermore, there was a strong
ositive correlation between the number of TREC
cells per microliter and TREC T cells per 100 000
cells (Figure 2D), thus indicating that both param-
ters can be used equivalently. Data are presented as
REC T cells per microliter, because this parameter
s a better indicator of thymopoiesis. Overall numbers
f peripheral TREC T cells after stem cell trans-
lantation are shown in Figure 1.
ntracellular Expression of Ki67 in
eripheral T Cells
Relative representation of the 4 major categories
matched related, unrelated, haploidentical, and autol-
gous transplants) in the 81 patients in whom Ki67
xpression was studied was not different from that in
he total population (data not shown). Spontaneous
xpression of Ki67 in peripheral T cells was signiﬁ-
antly higher in patients studied before day 180
mean, 1.8%; 95% conﬁdence interval [CI], 1.33%-
.54%; n  27) than after day 180 after transplanta-
ion (mean, 0.83%; 95% CI, 0.68%-1.03%; n  65).
i67 expression was positively correlated between
ll T-cell subsets (naive CD4/memory CD4, naive
D4/naive CD8, naive CD4/memory CD8, memory
D4/naive CD8, memory CD4/memory CD8, and
n
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Thymic Function after Pediatric Stem Cell Transplantation
Baive CD8/memory CD8; correlation coefﬁcient,
.29-0.46), and this indicates that proliferation in
hese populations is likely to be driven by a common
actor. It is interesting to note that Ki67 expression in
aive and memory CD4 and CD8 T cells was
nversely correlated with CD3 T-cell numbers, thus
uggesting that spontaneous proliferation of these
opulations in the early posttransplantation phase is
igure 3. Acute GVHD reduces Ki67 expression in naive CD8 T
ells. Acute GVHD (grade II-IV) resulted in a reduced expression of
i67 in naive CD8 T cells after transplantation of unmanipulated
one marrow from matched sibling donors. However, this did not
each statistical signiﬁcance after transplantation of T cell–depleted
eripheral blood stem cells (A). No effect of acute or chronic
VHD on Ki67 expression in naive CD4T cells (B) or in memory
D4, memory CD8, and cytotoxic T lymphocyte CD8 popu-
ations could be observed (data not shown). Results were compared
y 1-way analysis of variance. Diamonds represent means  95%
onﬁdence intervals; n indicates the number of analyzed samples.riven by homeostatic mechanisms (correlation coef- p
B & M Tcient, 0.28 to 0.38). Furthermore, we were
nable to detect a signiﬁcant inﬂuence of T-cell
epletion or GVHD on Ki67 expression in most pop-
lations. However, naive CD8 T cells, but not naive
D4 T cells, of patients with a history of GVHD
fter unmanipulated bone marrow transplantation
howed a signiﬁcantly lower expression of Ki67
mean, 0.3%; 95% CI, 0.8%-2.3%; and mean, 1.4%;
5% CI, 0.1%-0.7% in patients with versus without
VHD, respectively; P  .0141). This phenomenon
ould not be found in patients with GVHD after
D34-selected PBSCs (Figure 3). In contrast, Ki67
xpression in effector CD8 T cells was not corre-
ated with any of the analyzed parameters. Therefore,
he proliferation of effector CD8 T cells seems to be
riven by other factors that were not evaluated in this
tudy.
actors Influencing the Onset of Thymic Activity
The onset of thymic activity was deﬁned as the time
oint Tmin, when patients switched from TREC
 to
REC samples. In the 83 patients in whom Tmin
ould be studied, relative representation of the 4 ma-
or categories (matched related, unrelated, haploiden-
ical, and autologous transplants) was not different
rom that of the total study population (n  164). In
he ﬁrst step of analysis, we split our cohort of patients
nto 4 quartiles according to age. From this model, we
alculated that the median time to switch is 83 days for
hildren younger than 1 year at transplantation and
ncreases by 14 days with every year of life. In addi-
ion, there was a positive correlation between patient
ge and Tmin (Figure 4). The median time up to the
witch to positive TREC values occurred almost 2
onths earlier in patients who underwent transplan-
igure 4. The onset of thymic function Tmin is positively corre-
ated with patient age. The onset of thymic function Tmin was
stimated by using a maximum-likelihood model, explicitly tak-
ng into account missing values by interval-censoring the obser-
ations. A preliminary analysis based on regression of Tmin and
ge grouped according to quartiles showed a linear association.
n a model of linear ﬁt, Tmin was positively correlated with
atient age (P  .0001).
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2ation on account of a nonmalignant disease compared
ith patients who had malignant diseases (median:
06 versus 148 days in patients with malignant versus
onmalignant diseases, respectively). However, be-
ause of the unequal distribution of samples in the 2
roups (n  128 versus n  36), this difference failed
o reach statistical signiﬁcance (P  .21; Table 3).
ype of graft, donor, conditioning regimen, and
ransplanted stem cell number had no effect on the
nset of thymic activity. Furthermore, there was no
tatistically signiﬁcant difference for Tmin between
utologous and allogeneic transplantations. In con-
rast to the beneﬁcial effects of younger age and non-
alignant disease, acute GVHD (grade II-IV) and
hronic GVHD (limited and extensive) delayed the
witch to TREC positivity by 151 days (median; P 
036) and 184 days (median; P  .16), respectively.
owever, subjecting age and acute GVHD to a mul-
ifactorial model, only age could be conﬁrmed to have
signiﬁcant effect on Tmin. Although acute GVHD
elayed the onset of thymic recovery by 149 days
mean; 95% CI, 2 to 378 days), this difference was
ot signiﬁcant because of the inclusion of 0 in the
5% CI.
To rule out alternative explantations for the associ-
tion between patient age and Tmin, we examined
hether an earlier arrest of peripheral expansion in
ounger children might lead to higher TREC levels.
owever, we could not detect any correlation between
atient age and Ki67 expression, either in naive and
emory CD4 and CD8T cells or in CD8 cytotoxic
lymphocytes (data not shown). Furthermore, the dis-
ribution of T cell–depleted versus T cell–replete grafts
as not different among age quartiles (30 T cell–de-
leted versus 10 T cell–replete grafts in patients 3.7
ears; 30 versus 12 in patients between 3.8 and 7.3 years;
5 versus 16 in patients between 7.4 and 12.4 years; and
1 versus 10 in patients12.6 years; P .43). Thus, the
ositive correlation between patient age and Tmin cannot
e explained by differences in homeostatic proliferation
r graft composition.
actors Influencing the Plateau Level of
REC Values
After the initial increase in TREC values, patients
chieved a plateau level PL of TRECs after 18 to 24
onths that remained constant over time (Figure 1).
e considered PL in this case as a second parameter
hat describes thymic function in a more stable phase
nd analyzed the inﬂuence of the above-mentioned
ariables on the height of PL. It is interesting to note
hat the only variable that had a signiﬁcantly positive
ffect on PL was transplanted stem cell number. Pa-
ients who received more than 107 CD34 PBSCs per
ilogram body weight had signiﬁcantly higher TRECs
n the plateau phase than patients who received lower t
00tem cell doses (8878 versus 3268 median TRECs per
00 000 T cells in patients with higher versus lower
tem cell numbers; P  .002; Figure 5A). However,
here was no positive correlation between stem cell
ose and the plateau of thymic function (Figure 5B),
hus suggesting that this phenomenon is a threshold
ffect rather than a linear association. All other ana-
yzed factors, including age and type of disease, failed
o have a beneﬁcial effect on thymic output. Further-
ore, PL did not differ between autologous or allo-
eneic transplantations. As in the analysis of the onset
f thymic activity, in a 1-way analysis of variance, both
cute (grade II-IV) and chronic (limited and extensive)
VHD signiﬁcantly impaired thymic function and
esulted in lower TREC levels in the plateau phase
median TRECs per 100 000 T cells: 2707 versus
102 in patients with versus without acute GVHD [P
.0395] and 1381 versus 4628 in patients with versus
ithout chronic GVHD [P  .0359]; Figure 5C and
). However, in a multivariate analysis, cell dose
107 CD34 PBSCs per kilogram) remained the
nly parameter associated with higher TREC levels in
he plateau phase PL of thymic output (P  .0022;
able 3).
In 4 patients analyzed more than 10 years after
ransplantation, there seemed to be a substantial de-
line in TREC values (Figure 1). Therefore, we re-
eated our analysis after exclusion of these patients.
ven with this less inclusive deﬁnition, CD34 cell
ose remained the only parameter with a signiﬁcant
ffect on the plateau of thymic function in a multivar-
ate analysis (P  .002).
REC Values in Sorted Naive and Memory
-Cell Subpopulations
As expected, in healthy adult controls, TREC lev-
ls were high in puriﬁed naive CD4 and CD8 T
ells but remained low or even undetectable in the
orresponding memory populations (Figure 6). On
he basis of the assumption that naive T cells in the
eripheral blood mirror the thymic output of RTEs,
ne would expect to ﬁnd a high TREC content in
aive T cells repopulating the empty T-cell pool after
ransplantation. However, TREC content in sorted
aive CD4 and CD8 T cells in the ﬁrst 6 months
fter transplantation was substantially diminished
Figure 6), thus indicating that TRECs in this phase of
mmune reconstitution are rapidly cleared in the pe-
iphery by an increased rate of cell division or by
poptotic cell death of RTEs. After 6 months, when
i67 expression had signiﬁcantly declined (described
reviously), TREC content in naive CD4 and CD8
cells normalized rapidly but remained low or unde-
ectable in memory T cells (Figure 6).
Table 3. Factors Inﬂuencing Onset Tmin and Plateau Level P of Thymic Activity
Variable
Tmin at Median Age of
7.4 y (d) P Value
Plateau TRECs
(TRECs per 105 T cells) P Value
Age quartiles (<3.7|3.8-7.3|7.4-12.4|>12.6| y) 109 versus 166 versus 216
versus 298
<.002 (n  40 versus 42
versus 41 versus 41)*
5378 versus 5765 versus 3139
versus 3047
.21 (n  30 versus 27
versus 23 versus 21)
Cell dose (<107 versus >107 CD34/kg BW) 190 versus 179 .65 (n  71 versus 43) 3268 versus 8878 .002 (n  37 versus 29)†
Graft (BM versus TCD PBSC) 162 versus 199 .46 (n  54 versus 104) 3239 versus 5107 .25 (n  39 versus 59)
Donor (matched sibling versus unrelated versus
parental versus autologous)
187 versus 195 versus 187
versus 187
.84 (n  35 versus 45
versus 18 versus 51)
3050 versus 3002 versus 7388
versus 6599
.053 (n  35 versus 22
versus 11 versus 33)
Conditioning (TBI versus busulfan versus other) 164 versus 191 versus 211 .58 (n  57 versus 55
versus 50)
3056 versus 3785 versus 6812 .058 (n  29 versus 39
versus 32)
Acute GVHD (no acute GVHD versus acute
GVHD grade II–IV)
164 versus 313 .036 (n  121 versus 36)* 5102 versus 2707 .0395 (n  74 versus 27)†
Chronic GVHD (no chronic GVHD versus
chronic GVHD [limited & extensive])
182 versus 366 .16 (n  152 versus 12) 4628 versus 1381 .0359 (n  95 versus 6)†
Disease (malignant versus nonmalignant) 206 versus 148 .21 (n  128 versus 36) 3996 versus 5235 .38 (n  73 versus 28)
Inﬂuence of variables on Tmin was estimated by maximum likelihood, and signiﬁcance was calculated with the likelihood ratio test. Age dependency of Tmin could be conﬁrmed for all variables; results
for Tmin are given at the median age of the cohort (7.4 years). Plateaus of TRECs were compared by 1-way analysis of variance; n indicates the number of samples analyzed in each group.
BW indicates body weight; TCD PBSC, T cell–depleted peripheral blood stem cells; TBI, total body irradiation.
*Entering age and acute GVHD in a multifactorial model for estimation of Tmin, only younger recipient age resulted in a shorter time to Tmin. The inﬂuence of acute GVHD did not remain signiﬁcant
(delay of Tmin by acute GVHD: 149 days; 95% CI, 2 to 378 days).
†In a multivariate analysis, only cell dose was associated with higher plateau TREC levels (P  .0022).
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2ISCUSSION
Recently, accumulating evidence for the persisting
ctivity of the thymus in adults and its importance for
aive T-cell regeneration after stem cell transplanta-
ion or human immunodeﬁciency virus infection has
ed to a number of studies focusing on thymic function
n such clinical situations. Although the thymus is
onsidered to be most active before the onset of pu-
erty, data on thymic function based on the assess-
ent of TREC levels in children after stem cell trans-
lantation have been scarce. Only 1 study included a
mall cohort of children among a larger group of
dults [27]; a few studies dealt with TREC reconsti-
ution in children with immunodeﬁciencies [5,26].
ur aim in this study was therefore to analyze T-cell
ynamics and thymic function in a purely pediatric
ohort of patients after autologous and allogeneic
tem cell transplantation. Although the TREC assay
igure 5. Inﬂuence of transplanted stem cell number on the plateau
evel PL of TRECs. Patients receiving more than 107 CD34 cells
er kilogram body weight had signiﬁcantly higher TRECs in the
lateau phase of thymic reconstitution (A). However, the associa-
ion between stem cell dose and plateau level PL was not linear (B),
hus suggesting that 107 CD34 cells per kilogram body weight is
threshold dose for a better thymic output. Younger age and
onmalignant disease, which resulted in a faster onset of thymic
ecovery, did not inﬂuence TREC levels in this phase. In a 1-way
nalysis of variance, both acute GVHD (C) and chronic GVHD (D)
ecreased TREC levels signiﬁcantly, whereas other transplant-re-
ated factors, such as conditioning regimen and type of donor or
raft, had no effect (data not shown). However, a multivariate
nalysis conﬁrmed only stem cell number to have a signiﬁcant effect
n PL. Diamonds represent means  95% conﬁdence intervals; n
ndicates the number of analyzed samples.epresented a very important tool for immune moni- C
02oring [4,8], it soon became clear that the interpreta-
ion of TREC data can be hampered by the rapid
learance of TREC T cells from the peripheral
lood or by the longevity of resting TREC naive T
ells [18,19]. In situations in which no steady-state
onditions for the peripheral T-cell pool can be as-
umed, information about the T-cell turnover state
ust therefore be taken into account to interpret
REC data correctly. By combining the quantiﬁcation of
RECs in PMNCs and sorted T-cell populations
ith ﬂow cytometry of peripheral T-cell subsets and
imultaneous measurement of intracellular Ki67 ex-
ression, we were able to identify novel aspects of
-cell dynamics after stem cell transplantation in
hildren.
The early period of immune reconstitution after
tem cell transplantation is characterized by a high
ate of spontaneous T-cell divisions, as determined by
he intracellular expression of Ki67 [13]. Ki67 is a
uclear antigen that is expressed in all phases of the
ell cycle except G0, and its expression correlates with
-cell proliferation measured by thymidine incorpo-
ation assays [29]. Expression of Ki67 was not found to
iffer signiﬁcantly between naive and memory CD4
nd CD8 T-cell populations but was correlated
mong all subsets; this indicates that there is a com-
igure 6. TREC content in sorted naive and memory CD4 and
D8 T cells. TRECs were high in sorted naive CD4 and CD8
cells from healthy adult controls but were very low in the
orresponding memory populations. In transplant recipients during
he ﬁrst 180 days after transplantation, TREC content in naive T
ells was substantially diminished, thus indicating rapid clearance of
REC T cells from the naive T-cell pool. After 6 months, when
i67 expression had signiﬁcantly declined, TREC content in the
aive CD4 and CD8 T-cell populations of the patients rapidly
ormalized, whereas TRECs remained undetectable in memory T
ells. Logarithmic transformation of TRECs was applied to achieve
qual variances among groups. Diamonds represent means  95%
onﬁdence intervals; n indicates the number of analyzed samples.
omparisons for all pairs were made with the Tukey-Kramer test.
m
t
i
i
s
o
f
d
i
t
r
G
p
K
c
a
f
C
p
e
t
s
d
t
l
s
t
t
c
c
c
t
b
o
n
K
t
i
T
c
p
s
p
F
t
f
T
P
T
p
c
t
1
a
m
t
c
q
t
v
m
r
c
n
t
n
T
p
l
n
s
b
e
w
T
t
a
r
B
f
t
w
l
t
n
w
c
s
t
b
t
b
o
T
t
e
B
i
c
p
a
t
a
t
T
t
t
p
o
l
e
Thymic Function after Pediatric Stem Cell Transplantation
Bon factor that drives T-cell expansion soon after
ransplantation and that affects all T-cell populations
n a similar fashion. The only parameter that was
nversely correlated with Ki67 expression in all T-cell
ubsets except effector CD8 T cells was the number
f peripheral CD3 T cells. This ﬁnding strongly
avors the concept that lymphopenia itself is a major
riving force for homeostatic proliferation of T cells
n the context of immune reconstitution after stem cell
ransplantation [30,31]. We could not conﬁrm the
esults of Hazenberg et al. [13], who identiﬁed only
VHD and infection as factors responsible for T-cell
roliferation but did not detect a correlation between
i67 expression and peripheral T-cell numbers. In
ontrast, in naive CD8 T cells from children with
cute GVHD after bone marrow transplantation, we
ound signiﬁcantly reduced expression of Ki67. In
D4 and CD8 memory and CD8 effector T-cell
opulations, there was also a trend toward a lower
xpression of Ki67 in patients with GVHD, although
his did not reach statistical signiﬁcance (data not
hown). This discrepancy might be explained by the
ifferent ages of the study populations and by the fact
hat different stages of GVHD might have been ana-
yzed. However, a recent report by Poulin et al. [32],
howed that chronic GVHD does not alter prolifera-
ion rates in naive or memory T cells after transplan-
ation but reduces expression of the interleukin 7R
hain and the antiapoptotic protein Bcl-2 on naive T
ells, thus impairing survival of these cells. The in-
reased turnover of T cells in the ﬁrst 180 days after
ransplantation, together with the increased suscepti-
ility of RTEs to apoptosis [33], also explains the
bserved diminished content of TREC T cells in the
aive T-cell compartment during this phase. When
i67 expression declined after 180 days, TREC con-
ent in the naive T-cell compartment rapidly normal-
zed. This demonstrates that not only thymic export of
REC T cells, but also peripheral events, signiﬁ-
antly inﬂuence TREC content in the naive T-cell
ool in the early phase of immune reconstitution after
tem cell transplantation.
We then analyzed the course of TREC content in
eripheral T cells after transplantation, as shown in
igure 1, and deﬁned 2 stages of TREC reconstitu-
ion: (1) a switch from TREC negativity (which was
ound in all patients analyzed) to increasingly positive
REC values at time point Tmin and (2) a plateau level
of TRECs that is achieved after 18 to 24 months.
hese 2 stages were determined by different trans-
lant-related factors. We found that Tmin was strongly
orrelated with patient age, even in children before
he onset of puberty. TRECs became measurable in a
-year-old child after approximately 2.5 months. Each
dditional year delayed Tmin by 2 weeks. Further-
ore, this age dependency of Tmin could not be al-ernatively explained by differences in peripheral T- l
B & M Tell turnover state or graft composition among the age
uartiles. Certainly, this calculation underestimates
he speed of thymic recovery, because—as shown pre-
iously—TREC T cells might be short lived or
ight divide rapidly during this phase of immune
econstitution and remain undetectable. However, be-
ause increased T-cell division rates are comparable in
aive and memory T-cell populations, we would argue
hat this underestimation of thymic function affects
aive CD4 and naive CD8 pools harmonically.
hese data demonstrate that the onset of thymic out-
ut occurs much earlier than previously thought. De-
ineating thymic recovery from the detection of phe-
otypically naive T cells in the peripheral blood led to
uggestions that thymic reconstitution does not start
efore 6 months after transplantation [34,35]. The
arlier onset of thymic recovery implies that T cells
ith novel antigen speciﬁcities enter the peripheral
-cell pool earlier than previously thought. Vaccina-
ion programs might prove to be successful if initiated
s early as 3 months after transplantation, as is cur-
ently being investigated by a study of the European
one Marrow Transplantation Group working party
or infectious diseases. A similar beneﬁcial effect on
he onset of thymic function was found for children
ho underwent transplantation because of a nonma-
ignant disease. Although the difference in Tmin failed
o reach statistical signiﬁcance because of the smaller
umber of patients in the nonmalignant disease group,
e consider this difference of almost 2 months clini-
ally relevant. No other analyzed variables had any
igniﬁcant inﬂuence on Tmin. It is interesting to note
hat there was no apparent difference in Tmin and PL
etween autologous and allogeneic transplantations.
In contrast to Tmin, PL was determined only by
he number of transplanted CD34 stem cells and not
y recipient age, disease, conditioning regimen, and so
n. In this later stage of immune reconstitution,
REC levels can be regarded as a true estimate of
hymic function, because the increased T-cell prolif-
ration rate returned to baseline levels, and abnormal
cl-2/Bax ratios on peripheral T cells, resulting in
ncreased apoptosis, normalized after 2 years [36]. The
linical relevance of the higher thymic output in these
atients is still unclear. As demonstrated previously,
cute and chronic GVHD had a negative effect on
hymic function, both on the onset of thymic activity
nd on the plateau level of thymic output, although
heir inﬂuence failed to reach statistical signiﬁcance.
his is not surprising because the thymus is a direct
arget of donor-antihost alloreactivity and because
hymic architecture is severely disturbed in GVHD
atients [37]. Whether the decline in TREC values
bserved after 10 years represents an artifact of the
ow patient number (n  4) or is an actual phenom-
non remains to be determined in a larger cohort of
ong-term survivors.
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2In summary, our data provide novel insights into
he mechanisms of thymus-dependent T-cell recon-
titution after stem cell transplantation in children.
ost likely, the increasing age of the young patients
nd pretransplantation chemotherapy in children with
alignant diseases will reduce thymic cellularity,
hereby deﬁning a pretransplantation level of thymic
unctionality that cannot be improved by any of the
ransplant-related factors analyzed here. This pre-
eﬁned status of the thymus determines the onset of
hymic reconstitution after transplantation of hema-
opoietic progenitor cells. However, acute or chronic
VHD may result in further damage to thymic archi-
ecture. In the early phase of immune reconstitution,
he rapid production of RTEs and homeostatic events
ontribute to reﬁlling the peripheral T-cell pool, but
hese attempts are hampered by the limited availability
f competent precursors and by an increased suscep-
ibility of RTEs and mature T cells to apoptosis
32,36]. Once the T-cell dynamics have stabilized,
REC levels are higher in children who undergo
ransplantation with increased stem cell doses, prob-
bly as a result of a larger number of committed
ymphoid precursors that are available to enter the
hymic subcapsular zone.
Unfortunately, there are still no proven concepts in
linical use that clearly support thymic reconstitution.
owever, several promising approaches are currently
eing tested in animal studies, and their physiological
athways are in accordance with our observations. The
se of ﬁbroblast growth factors such as keratinocyte
rowth factor might restore thymic cellularity and en-
ance the production of thymocytes [38], whereas T
ell–speciﬁc cytokines such as interleukin 7 seem to im-
rove the survival and cycling of RTEs and peripheral T
ells [39,40]. Amelioration of thymic reconstitution will
ertainly reconcile the skewed patterns of T-cell recon-
titution after transplantation with the pathways of nor-
al T-cell ontogeny.
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